ASRT: Assertio Holdings Quarterly Revenue Growth

Public company logo of Assertio Holdings, Inc. (ASRT)

Assertio Holdings, Inc. is scaling analgesic sales through the acquisition of niche brands and partnerships with distributors. The quarterly revenue dynamics chart visualizes this trend, where -62.40 determines the latest valuation metric. However, expansion is constrained by pressure from low-cost generics and marketing expenses, while the current priority has shifted toward debt reduction and organic sales growth.

ASRT Assertio Holdings, Inc. Quarterly Revenue Growth Rate (07/04/2022 - 06/27/2026)

Financial and market metric breakdowns for Assertio Therapeutics (ASRT)

- share price and expert price forecast:
- money and cash flow information:
Fundamental company analysis:ASRT - Assertio Holdings, Inc.
Manufactured products of Assertio Holdings

The ability of Assertio Holdings, Inc. (ASRT) to withstand generic expansion and the loss of patent protection depends directly on the stability of its commercial revenue stream. By analyzing quarterly commercial revenue trends, an investor filters out market noise to assess the real growth rate of sales between reports, allowing for the timely detection of eroding market positions or the confirmation of the business's fundamental strength for long-term investment.

Direct competitors

BIIB - Revenue Growth QoQ|NBIX (Neurocrine Biosciences) - Sales Growth QoQ|RGC: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Axsome (AXSM)|Revenue Growth QoQ ACADIA Pharmaceuticals Inc|Quarterly Sales Growth Xenon Pharmaceuticals Inc (XENE)|Quarterly Revenue Growth VKTX|Quarterly Revenue Growth supernus.com (SUPN)|Revenue Growth QoQ Catalyst Pharmaceuticals, Inc. CPRX|DNLI (Denali Therapeutics Inc.) - Revenue Dynamics QoQ|Harmony Corp - Quarterly Revenue Growth|BHVN: Revenue Growth QoQ|AMLX: Quarterly Revenue Growth|TRVI: Sales Change QoQ|Revenue Growth QoQ Praxis Medicines|Quarterly Revenue Growth Rate Anavex AVXL|Revenue Growth QoQ CeriBell Corp (CBLL)|Sales Change QoQ PRTA|Quarterly Revenue Growth ALEC (Alector)|Annexon (ANNX) - Quarterly Revenue Growth Rate|OMER - Revenue Growth QoQ|NGNE (Neurogene) - Sales Growth QoQ|ACIU: Quarterly Revenue Growth|VYGR - Quarterly Sales Growth Rate|Revenue Growth QoQ Neumora Therapeutics, Inc.|Sales Growth QoQ SCLX (Scilex)|Quarterly Sales Growth TVGN (Tevogen Bio)|Quarterly Revenue Growth Alpha Cognition Inc (ACOG)|Quarterly Revenue Growth CGTX (cogrx.com)|Quarterly Sales Growth Rate Inhibikase Pharma (IKT)|SAVA: Quarterly Sales Growth|Quarterly Revenue Growth Rate Coya Therapeutics Inc|Vistagen Therapeutics (VTGN) - Revenue Growth QoQ|OVID - Quarterly Sales Growth Rate|Revenue Growth QoQ Acumen Pharmaceuticals, Inc|Revenue Growth QoQ CRVO|Quarterly Revenue Growth ATHE|Clene - Sales Growth QoQ|Quarterly Revenue Growth PEPG (pepgen.com)|JUNS: Sales Growth QoQ|RLMD - Revenue Growth QoQ|Quarterly Revenue Growth Rate Annovis Bio, Inc.|GRCE (Grace Therapeutics) - Quarterly Sales Growth|Quarterly Revenue Growth Rate Firefly Neuroscience (AIFF)|Quarterly Sales Growth KLTO|NRSN: Quarterly Revenue Increase|Revenue Growth QoQ Reviva Pharmaceuticals Holdings (RVPH)|Quarterly Sales Growth MetaVia, Inc. MTVA|Revenue Growth QoQ NeurAxis NRXS|HSDT: Sales Growth QoQ|passagebio.com - Quarterly Revenue Growth|NEUP - Quarterly Revenue Growth|Minerva Neurosciences Corp (NERV) - Revenue Growth QoQ|Revenue Dynamics QoQ ATHA (Athira)|ADXN (Addex Therapeutics Ltd.) - Quarterly Revenue Growth|Sales Growth QoQ ALZN (Alzamend Neuro)|Revenue Growth QoQ Cyclerion Therapeutics Inc. (CYCN)|Quarterly Revenue Growth Protagenic Therapeutics, Inc. (PTIX)|Quarterly Revenue Growth KTTA (Pasithea Therapeutics Corp)|CRGT - Quarterly Sales Growth|ATXI - Revenue Growth QoQ|BCLI: Revenue Growth QoQ|Cara Therapeutics (CARA) - Revenue Growth QoQ|Quarterly Revenue Growth Rate Chromocell Therapeutics Corp (CHRO)|Quarterly Sales Growth ELYM|Quarterly Revenue Growth Rate intracellulartherapies.com ITCI|Revenue Growth QoQ Longboard Pharmaceuticals (LBPH)|MRNS (Marinus Pharmaceuticals) - Quarterly Revenue Increase|Revenue Growth QoQ NKGen NKGN|Quarterly Revenue Growth NeuroBo Pharmaceuticals Inc NRBO|SAGE: Quarterly Sales Growth|Quarterly Sales Growth Rate Synaptogenix, Inc SNPX|TRVN: Quarterly Revenue Growth|Quarterly Revenue Growth Rate Vigil Neuroscience (VIGL)|Revenue Growth QoQ Anew Medical, Inc.|CERE (Cerevel Therapeutics, Inc.) - Sales Change QoQ